FDA Just Fast-Tracked a Vaccine for Alzheimer's
A vaccine that targets amyloid beta in the brain to treat Alzheimer's disease has been granted fast-track designation by the FDA.
The U.S. Food and Drug Administration granted fast-track designation to UB-311, a vaccine for Alzheimer’s disease made by biotechnology company Vaxxinity
Aside from the potential problems that can arise when a vaccine is rushed to market, the vaccine may be problematic from the get-go because amyloid beta may be a symptom of Alzheimer’s,…
Keep reading with a 7-day free trial
Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.